Recombinant CD35 antibody (full length)
Quick Overview for Recombinant CD35 antibody (full length) (ABIN7877996)
Target
See all CD35 (CR1) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- full length
-
Purpose
- Recombinant CD35 Antibody
-
Purification
- Protein A/G affinity
-
Immunogen
- Recombinant full-length human CR1 protein was used as the immunogen for the recombinant CD35 antibody.
-
Isotype
- IgG, kappa
-
-
-
-
Application Notes
- Optimal dilution of the recombinant CD35 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the recombinant CD35 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- CD35 (CR1) (Complement Component Receptor 1 (CD35) (CR1))
-
Alternative Name
- CD35
-
Background
- CD35, complement receptor 1, is a cell membrane-bound, monomeric glycoprotein on numerous cell types including erythrocytes, leukocytes, glomerular podocytes, and follicular dendritic cells. The primary function of CD35 is to serve as the cellular receptor for C3b and C4b, the most important components of the complement system leading to clearance of foreign macromolecules. CD35 antigen is found on erythrocytes, B cells, a subset of T cells, monocytes, as well as eosinophils, and neutrophils. Anti-CD35 is considered a mature B-cell marker which labels follicular dendritic reticulum cells and tumors derived from such cells such as follicular dendritic cell tumor/sarcoma.
-
UniProt
- P17927
-
Pathways
- Complement System, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Endopeptidase Activity
Target
-